Post-marketing Commitments

Continuing research on our medicines after FDA approval allows us to innovate and improve the quality of life for our patients. The studies, testing, and other activities that Daiichi Sankyo, Inc. conducts in agreement with the FDA are known as post-marketing commitments (PMCs) and post-marketing requirements (PMRs).

For more information about Daiichi Sankyo, Inc.'s PMCs and PMRs, please visit the FDA’s Post Marketing Requirements and Commitments Database. By maintaining these commitments, we strive to ensure that our medicines continue to meet the highest standards of safety and efficacy.